IGC Pharma, Inc.IGCNYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank71
3Y CAGR-43.6%
5Y CAGR+40.4%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-43.6%/yr
vs +89.2%/yr prior
5Y CAGR
+40.4%/yr
Recent deceleration
Acceleration
-132.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
5.5x
Strong expansion
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 17.03 | -15.7% |
| 2024 | 20.19 | +21.5% |
| 2023 | 16.61 | -82.5% |
| 2022 | 94.68 | +37.9% |
| 2021 | 68.64 | +2098.1% |
| 2020 | 3.12 | -65.2% |
| 2019 | 8.98 | +21.4% |
| 2018 | 7.39 | -69.7% |
| 2017 | 24.41 | +1477.8% |
| 2016 | 1.55 | - |